Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tryptase as severity marker in drug provocation tests.

P Komericki1, E Arbab, R Grims

  • 1Department of Environmental Dermatology and Venereology, Medical University Graz, Graz, Austria. peter.komericki@meduni-graz.at

International Archives of Allergy and Immunology
|April 8, 2006
PubMed
Summary

Serum tryptase levels are not helpful in distinguishing between allergic and "hysterical" drug reactions. Mild reactions showed no consistent increase in tryptase, suggesting limited mast cell activation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors Affecting the Safety and Effectiveness of Venom Immunotherapy.

Journal of investigational allergology & clinical immunology·2023
Same author

Arerugi = [Allergy]·2023
Same author

Arerugi = [Allergy]·2023
Same author

Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis.

Allergy·2023
Same author

Variability of disease activity in patients with hereditary angioedema type 1/2: longitudinal data from the Icatibant Outcome Survey.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

[Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI-AeDA-GPA-DGAKI Position Paper (Pocket-Guide)].

Laryngo- rhino- otologie·2020

Area of Science:

  • Clinical Immunology
  • Pharmacology

Background:

  • Assessing adverse drug reactions during provocation testing is challenging without objective symptoms.
  • Differentiating between true reactions and 'hysterical' (conversion) symptoms is crucial.

Purpose of the Study:

  • To evaluate the utility of serum tryptase levels in distinguishing positive, negative, and 'hysterical' drug reactions.
  • To determine if serum tryptase changes correlate with reaction severity.

Main Methods:

  • A prospective single-center study involving 303 patients and 785 drug provocation tests.
  • Serum tryptase levels were measured before and after drug challenge.
  • Changes in tryptase were compared between patients with and without objective reactions.

Main Results:

Related Experiment Videos

  • Thirty-four tests were clinically judged as positive.
  • Median serum tryptase levels decreased slightly, though not significantly, in patients with objective symptoms.
  • A statistically significant decrease in post-testing tryptase was observed in patients without objective reactions.

Conclusions:

  • Serum tryptase measurement is not effective in differentiating mild allergic/nonallergic from 'hysterical' drug reactions.
  • A mild decrease in tryptase may suggest minor mast cell activation in some objective reactions.
  • More severe reactions correlated with greater mast cell degranulation, while mild reactions did not consistently elevate tryptase.